Trial Profile
Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Lurasidone (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Sumitomo Dainippon Pharma
- 28 Jun 2014 New trial record